BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27513204)

  • 1. The use of brincidofovir for the treatment of mixed dsDNA viral infection.
    Camargo JF; Morris MI; Abbo LM; Simkins J; Saneeymehri S; Alencar MC; Lekakis LJ; Komanduri KV
    J Clin Virol; 2016 Oct; 83():1-4. PubMed ID: 27513204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.
    Florescu DF; Keck MA
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1171-8. PubMed ID: 25120093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections.
    Alvarez-Cardona JJ; Whited LK; Chemaly RF
    Future Microbiol; 2020 Apr; 15():389-400. PubMed ID: 32166967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.
    Papanicolaou GA; Lee YJ; Young JW; Seshan SV; Boruchov AM; Chittick G; Momméja-Marin H; Glezerman IG
    Am J Kidney Dis; 2015 May; 65(5):780-4. PubMed ID: 25600489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
    Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
    El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
    Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - Case series and 10 year experience of management in an adult transplant cohort.
    Ramsay ID; Attwood C; Irish D; Griffiths PD; Kyriakou C; Lowe DM
    J Clin Virol; 2017 Nov; 96():73-79. PubMed ID: 29017084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brincidofovir as Salvage Therapy for Adenovirus Disease in Intestinal Transplant Recipients.
    Sulejmani N; Nagai S; Safwan M; Rizzari MD; Raoufi M; Abouljoud MS; Ramesh M
    Pharmacotherapy; 2018 Apr; 38(4):470-475. PubMed ID: 29457839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001.
    Paolino K; Sande J; Perez E; Loechelt B; Jantausch B; Painter W; Anderson M; Tippin T; Lanier ER; Fry T; DeBiasi RL
    J Clin Virol; 2011 Feb; 50(2):167-70. PubMed ID: 21094081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maribavir, brincidofovir and letermovir: Efficacy and safety of new antiviral drugs for treating cytomegalovirus infections.
    Frange P; Leruez-Ville M
    Med Mal Infect; 2018 Dec; 48(8):495-502. PubMed ID: 29650261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
    Mullane KM; Nuss C; Ridgeway J; Prichard MN; Hartline CB; Theusch J; Mommeja-Marin H; Larson RA
    Transpl Infect Dis; 2016 Oct; 18(5):785-790. PubMed ID: 27481400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.
    Florescu DF; Pergam SA; Neely MN; Qiu F; Johnston C; Way S; Sande J; Lewinsohn DA; Guzman-Cottrill JA; Graham ML; Papanicolaou G; Kurtzberg J; Rigdon J; Painter W; Mommeja-Marin H; Lanier R; Anderson M; van der Horst C
    Biol Blood Marrow Transplant; 2012 May; 18(5):731-8. PubMed ID: 21963623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.
    Grimley MS; Chemaly RF; Englund JA; Kurtzberg J; Chittick G; Brundage TM; Bae A; Morrison ME; Prasad VK
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):512-521. PubMed ID: 28063938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of adenovirus infection in immunocompromised patients.
    Matthes-Martin S; Boztug H; Lion T
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1017-28. PubMed ID: 24073835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The successful treatment of mpox with brincidofovir in renal transplant recipients-a report of 2 cases.
    Alameer RM; Yamani A; Al-Saud A; Alsobayeg S; Alamro B; Alali A; Hammad E; Shendi AM; Almaghrabi RS
    Int J Infect Dis; 2024 Jun; 143():107015. PubMed ID: 38521447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds.
    Toth K; Tollefson AE; Spencer JF; Ying B; Wold WSM
    Antiviral Res; 2017 Oct; 146():121-129. PubMed ID: 28827083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug on the horizon for treating adenovirus.
    Wold WS; Toth K
    Expert Opin Pharmacother; 2015; 16(14):2095-9. PubMed ID: 26330121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis.
    Lanier ER; Foster S; Brundage T; Chou S; Prichard MN; Kleiboeker S; Wilson C; Colville D; Mommeja-Marin H
    J Infect Dis; 2016 Jul; 214(1):32-5. PubMed ID: 26941282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients.
    Lee YJ; Neofytos D; Kim SJ; Cheteyan L; Huang YT; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
    Transpl Infect Dis; 2018 Dec; 20(6):e12977. PubMed ID: 30120866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BK virus encephalitis: case report, review of the literature, and description of a novel treatment modality.
    Chittick P; Williamson JC; Ohl CA
    Ann Pharmacother; 2013 Sep; 47(9):1229-33. PubMed ID: 24259742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.